EUVIMEDEUVIMED entdecken
Open Access

ORItavancin as a therapeutic regimen for Cardiac Implantable Electronic Devices infections with multidrug-resistant Gram-positive cocci (ORI-4-CIEDi) pilot study: rationale and design

Danuta Łoboda iD, Denis Swolana iD, Michał Joniec iD, Sylwia Gładysz-Wańha iD, Michał Gibiński iD, Karolina Simionescu iD, Eugeniusz Piłat, Krzysztof S Gołba iD, Robert D Wojtyczka iD, Sławomir Wilczyński iD, Beata Sarecka-Hujar iD

Cardiology Journal · 29.12.2025 · 32 (6) · 695-703

DOI: 10.5603/cj.107098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiology Journal, online erschienen am 29.12.2025. Verfasst von Danuta Łoboda und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrocardiology and Heart Failure, Faculty of Health Sciences in Katowice, Medical University of Silesia in Katowice, Poland. dloboda…. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Gram-positive bacterial infectionsdrug resistancehealthcare associated infectionsinfectious skin diseasesinfective endocarditistransvenous lead extraction

Autor:innen und Institutionen

  • Department of Electrocardiology and Heart Failure, Faculty of Health Sciences in Katowice, Medical University of Silesia in Katowice, Poland. dloboda@sum.edu.pl.
  • Department of Electrocardiology, Upper-Silesian Medical Centre in Katowice, Poland. dloboda@sum.edu.pl.
  • Department of Microbiology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Sosnowiec, Poland.
  • Department of Electrocardiology, Upper-Silesian Medical Centre in Katowice, Poland.
  • Doctoral School of the Medical University of Silesia in Katowice, Poland.
  • Department of Electrocardiology and Heart Failure, Faculty of Health Sciences in Katowice, Medical University of Silesia in Katowice, Poland.

ORCID-Profile: Danuta Łoboda, Denis Swolana, Michał Joniec, Sylwia Gładysz-Wańha, Michał Gibiński, Karolina Simionescu, Krzysztof S Gołba, Robert D Wojtyczka, Sławomir Wilczyński, Beata Sarecka-Hujar

Zitieren

APA

Łoboda, D., Swolana, D., Joniec, M., Gładysz-Wańha, S., Gibiński, M., Simionescu, K., Piłat, E., Gołba, K. S., Wojtyczka, R. D., Wilczyński, S., & Sarecka-Hujar, B. (2025). ORItavancin as a therapeutic regimen for Cardiac Implantable Electronic Devices infections with multidrug-resistant Gram-positive cocci (ORI-4-CIEDi) pilot study: rationale and design. Cardiology Journal, 32(6), 695-703. https://doi.org/10.5603/cj.107098

Vancouver

Łoboda D, Swolana D, Joniec M, Gładysz-Wańha S, Gibiński M, Simionescu K, et al. ORItavancin as a therapeutic regimen for Cardiac Implantable Electronic Devices infections with multidrug-resistant Gram-positive cocci (ORI-4-CIEDi) pilot study: rationale and design. Cardiology Journal. 2025;32(6):695-703. doi:10.5603/cj.107098

BibTeX
@article{oboda2025,
  author = {Łoboda, Danuta and Swolana, Denis and Joniec, Michał and Gładysz-Wańha, Sylwia and Gibiński, Michał and Simionescu, Karolina and Piłat, Eugeniusz and Gołba, Krzysztof S and Wojtyczka, Robert D and Wilczyński, Sławomir and Sarecka-Hujar, Beata},
  title = {ORItavancin as a therapeutic regimen for Cardiac Implantable Electronic Devices infections with multidrug-resistant Gram-positive cocci (ORI-4-CIEDi) pilot study: rationale and design},
  journal = {Cardiology Journal},
  year = {2025},
  volume = {32},
  number = {6},
  pages = {695--703},
  doi = {10.5603/cj.107098}
}
Kostenlos starten →